Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer

References

• Akao Y, Nakagawa Y, Naoe T. (2006). MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep, 16, 845–850.
   PubMed Web of Science ®Google Scholar
• Atkinson C, Frankenfeld CL, Lampe JW. (2005). Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med, 230, 155–170.
   PubMed Web of Science ®Google Scholar
• Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Cogliano V. (2007). Carcinogenicity of alcoholic beverages. Lancet Oncol, 8, 292–293.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. (2005). Host-bacterial mutualism in the human intestine. Science, 307, 1915–1920.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. (2005). Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A, 102, 16339–16344.
   PubMed Web of Science ®Google Scholar
• Basuroy S, Sheth P, Mansbach CM, Rao RK. (2005). Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Am J Physiol Gastrointest Liver Physiol, 289, G367–375.
   PubMed Web of Science ®Google Scholar
• Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. (2005). Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res, 589, 47–65.
   PubMed Web of Science ®Google Scholar
• Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C, Brigidi P, De Vos W. (2010). Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 17, e10667.
   Google Scholar
• Bingham SA. (2000). Diet and colorectal cancer prevention. Biochem Soc Trans, 28, 12–16.
   PubMed Web of Science ®Google Scholar
• Blaut M, Clavel T. (2007). Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr, 137, 751–S755S
   PubMed Web of Science ®Google Scholar
• Boquet P. (2001). The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon, 39, 1673–1680.
   PubMed Web of Science ®Google Scholar
• Boyer L, Travaglione S, Falzano L, Gauthier NC, Popoff MR, Lemichez E, Fiorentini C, Fabbri A. (2004). Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell, 15, 1124–1133.
   PubMed Web of Science ®Google Scholar
• Boyle P, Ferlay J. (1998). Cancer incidence and mortality in Europe. Ann Oncol, 16, 481–488.
   Google Scholar
• Bronowski C, Smith SL, Yokota K, Corkill JE, Martin HM, Campbell BJ, Rhodes JM, Hart CA, Winstanley C. (2008). A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn′s disease, share pathogenicity islands with urinary pathogenic E coli. Microbiology, 154, 571–583.
   PubMedGoogle Scholar
• Candela M, Bergmann S, Vici M, Vitali B, Turroni S, Eikmanns BJ, Hammerschmidt S, Brigidi P. (2007). Binding of human plasminogen to Bifidobacterium. J Bacteriol, 189, 5929–5936.
   PubMed Web of Science ®Google Scholar
• Candela M, Perna F, Carnevali P, Vitali B, Ciati R, Gionchetti P, Rizzello F, Campieri M, Brigidi P. (2008). Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol, 125, 286–292.
   PubMed Web of Science ®Google Scholar
• Carman RJ, Van Tassell RL, Kingston DG, Bashir M, Wilkins TD. (1988). Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutat Res, 206, 335–342.
   PubMed Web of Science ®Google Scholar
• Costarelli V. (2009). Bile acids as possible human carcinogens: new tricks from an old dog. Int J Food Sci Nutr, 3, 1–10.
   Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn′s disease. Gastroenterology, 127, 412–421.
   PubMed Web of Science ®Google Scholar
• Davis CD, Milner JA. (2009). Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem, 20, 743–752.
   PubMed Web of Science ®Google Scholar
• Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Muller O, Zimber A, Gespach C, Mareel MM. (2002). Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene, 21, 6740–6750.
   PubMed Web of Science ®Google Scholar
• Doye A, Mettouchi A, Bossis G, Clément R, Buisson-Touati C, Flatau G, Gagnoux L, Piechaczyk M, Boquet P, Lemichez E. (2002). CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell, 111, 553–564.
   PubMedGoogle Scholar
• Duerkop BA, Vaishnava S, Hooper LV. (2009). Immune responses to the microbiota at the intestinal mucosal surface. Immunity, 31, 368–376.
   PubMed Web of Science ®Google Scholar
• Elliott SJ, Srinivas S, Albert MJ, Alam K, Robins-Browne RM, Gunzburg ST, Mee BJ, Chang BJ. (1998). Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea. Infect Immun, 66, 2040–2051.
   Google Scholar
• Escobar-P´ramo P, Grenet K, Le Menac′h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R. (2004). Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol, 70, 5698–5700.
   Google Scholar
• Ewaschuk JB, Walker JW, Diaz H, Madsen KL. (2006). Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr, 136, 1483–1487.
   PubMed Web of Science ®Google Scholar
• Falzano L, Fiorentini C, Donelli G, Michel E, Kocks C, Cossart P, Cabanié L, Oswald E, Boquet P. (1993). Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol, 9, 1247–1254.
   Google Scholar
• Falzano L, Quaranta MG, Travaglione S, Filippini P, Fabbri A, Viora M, Donelli G, Fiorentini C. (2003). Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of pro-inflammatory cytokines in human uroepithelial cells. Infect Immun, 71, 4178–4181.
   Google Scholar
• Femia AP, Luceri C, Toti S, Giannini A, Dolara P, Caderni G. (2010). Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer, 10, 194–197.
   Web of Science ®Google Scholar
• Flint HJ, Duncan SH, Scott KP, Louis P. (2007). Interactions and competition within the microbial community of the human colon:links between diet and health. Environ Microbiol, 9, 1101–1111.
   PubMed Web of Science ®Google Scholar
• Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O′Brien DP, Romero-Gallo J, Peek Jr RM. (2005). Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A, 102, 10646–10651.
   PubMedGoogle Scholar
• Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A, 104, 13780–13785.
   PubMed Web of Science ®Google Scholar
• Freitas M, Axelsson LG, Cayuela C, Midtvedt T, Trugnan G. (2002). Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem Cell Biol, 118, 149–161.
   Web of Science ®Google Scholar
• Garrett WS, Gordon JI, Glimcher LH. (2010). Homeostasis and inflammation in the intestine. Cell, 140, 859–870.
   PubMed Web of Science ®Google Scholar
• Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. (2007). Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol Aug, 9, 2070–2080.
   PubMed Web of Science ®Google Scholar
• Ge Z, Schauer DB, Fox JG. (2008). In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol Aug, 10, 1599–15607.
   PubMed Web of Science ®Google Scholar
• Giamboi Miraglia A, Travaglione S, Meschini S, Falzano L, Matarrese P, Quaranta MG, Viora M, Fiorentini C, Fabbri A. (2007). Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2. Mol Biol Cell, 18, 2735–2744.
   Google Scholar
• Gibson GR. (2008). Prebiotics as gut microflora management tools. J Clin Gastroenterol, 42, S75–S79.
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. (2006). Metagenomic analysis of the human distal gut microbiome. Science, 312, 1355–1359.
   PubMed Web of Science ®Google Scholar
• Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, Khazaie K. (2009). T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting pro-inflammatory phenotype in polyposis. Cancer Res, 69, 5490–5497.
   PubMed Web of Science ®Google Scholar
• Guarner F, Malagelada JR. (2003). Gut flora in health and disease. Lancet, 361, 512–519.
   PubMed Web of Science ®Google Scholar
• Hahn A, Barth H, Kress M, Mertens PR, Goppelt-Struebe M. (2002). Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression. Biochem J, 362, 33–40.
   PubMed Web of Science ®Google Scholar
• Hattori M, Taylor TD. (2009). The human intestinal microbiome: a new frontier of human biology. DNA Res, 16, 1–12.
   PubMed Web of Science ®Google Scholar
• Hayashi T. (2006). Microbiology Breaking the barrier between commensalism and pathogenicity. Science, 313, 772–773.
   Google Scholar
• Henderson PT, Delaney JC, Gu F, Tannenbaum SR, Essigmann JM. (2002). Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry, 41, 914–921.
   PubMed Web of Science ®Google Scholar
• Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M. (2009). Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors. PLoS One, 4, Epub5184.
   Google Scholar
• Hope ME, Hold R, Kain GL, El-Omar EM. (2005). Sporadic colorectal cancer-role of the commensal microbiota. FEMS Microbiol Lett, 244, 1–7.
   PubMed Web of Science ®Google Scholar
• Horst D, Budczies J, Brabletz T, Kirchner T, Hlubek F. (2009). Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer. Cancer, 5, Epub.
   Google Scholar
• Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A. (2009). The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Cancer, 115, 2063–2070.
   PubMed Web of Science ®Google Scholar
• Humblot C, Lhoste E, Knasmuller S, Gloux K, Bruneau A, Bensaada M. (2004). Protective effects of Brussels sprouts, oligosaccharides and fermented milk towards 2-amino-3-methylimidazo[4,5-f]quinoline. (IQ). -induced genotoxicity in the human flora associated F344 rat: role of xenobiotic metabolising enzymes and intestinal microflora. J Chromatogr B Analyt Technol Biomed Life Sci, 29, 231–237.
   Google Scholar
• Hurmalainen V, Edelman S, Antikainen J, Baumann M, Lähteenmäki K, Korhonen TK. (2007). Extracellular proteins of Lactobacillus crispatus enhance activation of human plasminogen. Microbiol, 153, 1112–1122.
   Google Scholar
• Huycke MM, Gaskins HR. (2004). Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med, 229, 586–597.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, Ishiguro S, Miyaoka E, Sobue T, Kakizoe T. (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer, 116, 762–767.
   PubMed Web of Science ®Google Scholar
• International agency for research on cancer. (1973). Certain Polycyclic Aromatic Hydrocarbons and Heterocyclic Compounds. IARC, 3, 45, 91, 178.
   Google Scholar
• International agency for research on cancer. (1988). Alcohol Drinking. IARC, 44.
   Google Scholar
• International agency for research on cancer. (1993). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC, 56, 165.
   Google Scholar
• International agency for research on cancer Some inorganic substances, chlorinated hydrocarbons, aromatic amines. (1972). N-nitroso compounds and natural products. IARC, 1, 125.
   Google Scholar
• Jain D, Prasad KN, Sinha S, Husain N. (2008). Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol, 57, 267–272.
   PubMed Web of Science ®Google Scholar
• Jia W, Li H, Zhao L, Nicholson JK. (2008). Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov, 7, 123–129.
   PubMed Web of Science ®Google Scholar
• Kamano T, Mikami Y, Kurasawa T, Tsurumaru M, Matsumoto M, Kano M, Motegi K. (1999). Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer? Dis Colon Rectum, 42, 668–672.
   Google Scholar
• Kassaee MZ, Bekhradnia AR. (2003). The kinetics of interactions between fecapentaene-12 and DNA. J Biosci Bioeng, 95, 526–529.
   PubMed Web of Science ®Google Scholar
• Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol, 5, 104–112.
   PubMed Web of Science ®Google Scholar
• Killeen SD, Wang JH, Andrews EJ, Redmond HP. (2009). Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br J Cancer, 100, 1589–1602.
   PubMedGoogle Scholar
• Kuijsten A, Arts IC, Hollman PC, van′t Veer P, Kampman E. (2006). Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev, 15, 1132–1136.
   PubMed Web of Science ®Google Scholar
• Kraus S, Arber N. (2009). Inflammation and colorectal cancer. Curr Opin Pharmacol, 9, 405–410.
   PubMed Web of Science ®Google Scholar
• Kurdi P, Tanaka H, Van Veen HW, Asano K, Tomita F, Yokota A. (2003). Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria. Microbiol, 149, 2031–2037.
   PubMed Web of Science ®Google Scholar
• Kurdi P, van Veen HW, Tanaka H, Mierau I, Konings WN, Tannock GW, Tomita F, Yokota A. (2000). Cholic acid is accumulated spontaneously, driven by membrane delta pH, in many lactobacilli. J Bacteriol, 182, 6525–6528.
   Google Scholar
• Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, Takami H, Morita H, Sharma VK, Srivastava TP, Taylor TD, Noguchi H, Mori H, Ogura Y, Ehrlich DS, Itoh K, Takagi T, Sakaki Y, Hayashi T, Hattori M. (2007). Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res, 14, 169–181.
   PubMed Web of Science ®Google Scholar
• Lara-Tejero M, Gal´n JE. (2002). Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol, 10, 147–152.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, Raz E. (2010). ERK activation drives intestinal tumorigenesis in Apc (min/+) Mice. Nat Med, 16: 665–670.
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler KW, Vogelstein B. (1998). Genetic instabilities in human cancers. Nature, 396, 643–649.
   PubMed Web of Science ®Google Scholar
• Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. (1999). Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest, 104, 1107–1114.
   PubMed Web of Science ®Google Scholar
• Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI. (2008). Evolution of mammals and their gut microbes. Science, 320, 1647–1651.
   PubMed Web of Science ®Google Scholar
• Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI. (2008). Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol, 6, 776–788.
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. (2009). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett, 294, 1–8.
   PubMed Web of Science ®Google Scholar
• Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. (2007). Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe, 2, 119–129.
   PubMed Web of Science ®Google Scholar
• Macdonald TT, Monteleone G. (2005). Immunity, inflammation, and allergy in the gut. Science, 307, 1920–1925.
   PubMed Web of Science ®Google Scholar
• MahowaldMA Rey, FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, Cantarel BL, Coutinho PM, Henrissat B, Crock LW, Russell A, Verberkmoes NC, Hettich RL, Gordon JI. (2009). Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A, 106, 5859–5864.
   Google Scholar
• Malorni W, Fiorentini C. (2006). Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? FASEB J, 20, 606–609.
   PubMed Web of Science ®Google Scholar
• Mai V, McCrary QM, Sinha R, Glei M. (2009). Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J, 8, 49–59.
   Google Scholar
• Marnett LJ. (2000). Oxyradicals and DNA damage. Carcinogenesis, 21, 361–370.
   PubMed Web of Science ®Google Scholar
• Martin H, M, Campbell B, J, Hart C, A, Mpofu, C, Nayar, M, Singh, R, Englyst, H, Williams H, F&Rhodes, J M. (2004). Enhanced Escherichia coli adherence and invasion in Crohn′s disease and colon cancer. Gastroenterology, 127, 80–93.
   Google Scholar
• Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, Sprenger N, Fay LB, Kochhar S, van Bladeren P, Holmes E, Nicholson JK. (2007). A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol, 3, Epub112.
   Google Scholar
• Matos P, Jordan P. (2008). Increased Rac1b expression sustains colorectal tumor cell survival. Mol Cancer Res, 6, 1178–1184.
   PubMed Web of Science ®Google Scholar
• Maynard CL, Weaver CT. (2009). Intestinal effector T cells in health and disease. Immunity, 31, 389–400.
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Round JL, Kasper DL. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 453, 620–625.
   PubMed Web of Science ®Google Scholar
• McConnell BB, Yang VW. (2009). The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep, 5, 69–74.
   PubMedGoogle Scholar
• McConnell BB, Yang VW. (2009). The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep, 5, 69–74.
   PubMedGoogle Scholar
• McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Lozupone CA, Hamady M, Knight R, Bushman FD. (2008). The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog, 4, Epub20.
   Google Scholar
• McMahon B, Kwaan HC. (2008). The plasminogen activator system and cancer. Pathophysiol Haemost Thromb, 36, 184–194.
   PubMedGoogle Scholar
• Munro P, Flatau G, Doye A, Boyer L, Oregioni O, Mege JL, Landraud L, Lemichez E. (2004). Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem, 279, 35849–35857.
   Google Scholar
• Murphy KM, Travers P, Walport M. (2008). The Mucosal Immune System, in Janeway′s Immunobiology. Garland Publishing Inc London. 459–554.
   Google Scholar
• Neish AS. (2009). Microbes in gastrointestinal health and disease. Gastroenterol, 136, 65–80.
   PubMed Web of Science ®Google Scholar
• Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. (2006). Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science, 313, 848–851.
   PubMed Web of Science ®Google Scholar
• Obe G, Anderson D. (1987). Genetic effects of ethanol. Mutat Res, 186, 177–200.
   PubMed Web of Science ®Google Scholar
• O’Hara AM, Shanahan F. (2006). The gut flora as a forgotten organ. EMBO Rep, 7, 688–693.
   PubMed Web of Science ®Google Scholar
• O’Keefe SJ, Ou J, Aufreiter S, O′Connor D, Sharma S, Sepulveda J, Fukuwatari T, Shibata K, Mawhinney T. (2009). Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr, 139, 2044–2048.
   PubMed Web of Science ®Google Scholar
• O’Keefe SJ. (2008).Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 24, 51–58.
   PubMed Web of Science ®Google Scholar
• O’Keefe SJD, Chung D, Mahmoud N, Sepulveda AR, Manafe M, Arch J, Adada H, van der Merwe T. (2007). Why Do African Americans Get More Colon Cancer than Native Africans? J Nutr, 137, 175–S182S
   PubMed Web of Science ®Google Scholar
• Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A, Sciullo A, Sommi P, Fabbri A, Ricci V, Boquet P. (2009). Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog, 5, Epub1000603.
   Google Scholar
• Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. (2007). Development of the human infant intestinal microbiota. PLoS Biol, 5, 1556–1573.
   Web of Science ®Google Scholar
• Pédron T, Sansonetti P. (2008). Commensals bacterial pathogens and intestinal inflammation: an intriguing ménage ´ trios. Cell Host Microbe, 3, 344–347.
   PubMed Web of Science ®Google Scholar
• Peterson DA, Frank DN, Pace NR, Gordon JI. (2008). Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe, 3, 417–427.
   PubMed Web of Science ®Google Scholar
• Plummer SM, Grafstrom RC, Yang LL, Curren RD, Linnainmaa K, Harris CC. (1986). Fecapentaene-12 causes DNA damage and mutations in human cells. Carcinogenesis, 7, 1607–1609.
   PubMed Web of Science ®Google Scholar
• Pool-Zobel BL. (2005). Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr, 93, S73–90
   PubMedGoogle Scholar
• Povey AC, Schiffman M, Taffe BG, Harris CC. (1991). Laboratory and epidemiologic studies of fecapentaenes. Mutat Res, 259, 387–397.
   PubMed Web of Science ®Google Scholar
• Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O′Riordan M, O′Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins JK. (2007). Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr, 85, 488–496.
   PubMed Web of Science ®Google Scholar
• Rajilic-Stojanovic M, Smidt H, de Vos WM. (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol, 9, 2125–2136.
   PubMed Web of Science ®Google Scholar
• Rawls JF. (2007). Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe, 2, 73–74.
   Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. (2006). Bile salt biotransformations by human intestinal bacteria. J Lipid Res, 47, 241–259.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol, 9, 313–323.
   PubMed Web of Science ®Google Scholar
• Samba-Louaka A, Nougayrède JP, Watrin C, Jubelin G, Oswald E, Taieb F. (2008). Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell Microbiol, 10, 2496–2508.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Medzhitov R. (2009). Learning tolerance while fighting ignorance Cell, 138, 416–420.
   Google Scholar
• Sansonetti PJ. (2008). Host-bacteria homeostasis in the healthy and inflamed gut. Curr Opin Gastroenterol, 24, 435–439.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Di Santo JP. (2007). Debugging how bacteria manipulate the immune response. Immunity, 26, 149–161.
   PubMed Web of Science ®Google Scholar
• Scanlan PD, Shanahan F, Clune Y, Collins JK, O′Sullivan GC, O′Riordan M, Holmes E, Wang Y, Marchesi JR. (2008). Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol, 10,789–798.
   PubMed Web of Science ®Google Scholar
• Sears CL. (2009). Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev, 22, 349–369.
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humar´n LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensalbacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 105, 16731–16736.
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL. (2010). Microbiology: Genetic pot luck. Nature, 464: 837–838.
   Google Scholar
• Sonnenburg JL, Chen CT, Gordon JI. (2006). Genomic and metabolic studies of impact of probiotics on a model gut symbiont and host. PLoS Biol, 4, e413.
   PubMed Web of Science ®Google Scholar
• Stecher B, Hardt WD. (2008). The role of microbiota in infectious disease. Trends Microbiol, 16, 107–114.
   PubMed Web of Science ®Google Scholar
• Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD. (2007). Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol, 5, 2177–2189.
   PubMed Web of Science ®Google Scholar
• Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V. (2009). MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res, 315, 1439–1447.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman RH, Kersulyte D, Berg DE, Sasakawa C. (2009). Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe, 5, 23–34.
   PubMed Web of Science ®Google Scholar
• Tang J, Sharif O, Pai C, Silverman AL. (2009). Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease. Dig Dis Sci, 55, 1696–16703.
   PubMedGoogle Scholar
• Taieb F, Nougayrède JP, Watrin C, Samba-Louaka A, Oswald E. (2006). Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA- damage checkpoint-signalling pathway. Cell Microbiol, 8, 1910–1921.
   PubMed Web of Science ®Google Scholar
• Tang J, Sharif O, Pai C, Silverman AL. (2009). Mesalamine protects against colorectal cancer in inflammatory bowel disease. Dig Dis Sci, 25, Epub.
   Google Scholar
• Taieb F, Nougayrède JP, Watrin C, Samba-Louaka A, Oswald E. (2006). Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA- damage checkpoint-signalling pathway. Cell Microbiol, 8, 1910–1921.
   PubMed Web of Science ®Google Scholar
• Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppée JY, Bourdet-Sicard R, Sansonetti PJ, Pédron T. (2006). Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol, 176, 1228–1237.
   PubMed Web of Science ®Google Scholar
• Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. (2006). A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect, 12, 782–786.
   PubMed Web of Science ®Google Scholar
• Travaglione S, Fabbri A, Fiorentini C. (2008). The Rho-activating CNF1 toxin from pathogenic E coli: A risk factor for human cancer development? Infect Agent Cancer 3, 4.
   PubMedGoogle Scholar
• Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, Affourtit J, Egholm M, Henrissat B, Knight R, Gordon JI. (2010). Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad SciU S A, 107, 7503–7508.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. (2009a). A core gut microbiome in obese and lean twins. Nature, 457, 480–484.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. (2009b). The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med, 1, 6ra14.
   Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. (2007). The human microbiome project. Nature, 449, 804–810.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. (2006). Anobesity-associated gut microbiome with increased capacity for energy. harvest Nature, 444, 1027–1031.
   PubMed Web of Science ®Google Scholar
• Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. (2009). Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4, Epub6026.
   Google Scholar
• Van Baarlen P, Troost FJ, Van Hemert S, Van der Meer C, De Vos WM, De Groot PJ, Hooiveld GJ, Brummer RJ, Kleerebezem M. (2009). Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A, 106, 2371–2376.
   PubMed Web of Science ®Google Scholar
• Virchow R. (1863). Cellular Pathology as Based upon Physiological and Pathological Histology. Philadelphia, USA: JB Lippincott.
   Google Scholar
• Vogelstein B, Kinzler KW.(1995). Colorectal tumors The Genetic Basis of Human Cancer. New York: McGraw-Hill.
   Google Scholar
• Wu S, Morin PJ, Maouyo D, Sears CL. (2003). Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterol, 124, 392–400.
   PubMed Web of Science ®Google Scholar
• Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med, 15, 1016–1022.
   PubMed Web of Science ®Google Scholar
• Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, Henrissat B, Coutinho PM, Minx P, Latreille P, Cordum H, Van Brunt A, Kim K, Fulton RS, Fulton LA, Clifton SW, Wilson RK, Knight RD, Gordon JI. (2007). Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol, 5, 1574–1586.
   Google Scholar
• Zarkovic M, Qin X, Nakatsuru Y, Oda H, Nakamura T, Shamsuddin AM, Ishikawa T. (1993). Tumor promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcinogenesis, 14, 1261–1264.
   Web of Science ®Google Scholar
• Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. (2008). High-throughout diversity and functionality analysis of the gastrointestinal tract microbiota. Gut, 57, 1605–1615.
   PubMed Web of Science ®Google Scholar